4陈秀琴 蒋优君 梁黎.Diagnostic value of IGF—I and IGFBP—3 for growth hormone deficiency in children [J].浙江大学学报:医学版(in Chinese),2003,32(3):261-263.
5National Osteoporosis Foundation.Osteoporosis:review of the evidence for prevention,diagnosis,and treatment and cost-effectiveness analysis [J].Osteoporos Int,1998,8(Suppl 4):S1-S88.
6RIZZOLI R,BONJOUR J P.Determinants of peak bone mass and mechanisms of bone loss [J].Osteoporos Int,1999,9(Suppl 2):S17-S23.
7KORANYI J,SVENSSON J,GOTHERSTROM G,et al.Baseline characteristics and the effects of five years of GH replacement therapy in adults with GH deficiency of childhoodor adulthood onset:A comparative,prospective study [J]. J Clin Endocrinol Metab,2001,86(10):4 693-4 699.
8ATTANASIO A F,HOWELL S,BATES P C,et al.Body composition,IGF-1 and IG FBP-3 concentrations as outcome measures in severely GH-deficient (GHD) patients after childhood GH treatment:a comparison with adultonset GHD patients [J] .J Clin Endocrinol Metab,2002,87(7):3 368-3 372.
9SHALET S M,SHAVRIKOVA E,CROMER M,et al.Effect of growth hormone (GH) treatment on bone in Postpubertal GH-deficient patients:a 2-year randomized,controlled,dose-ranging study [J].J Clin Endocrinol Metab,2003, 88(9):4 124-4 129.
10BOOT A M,ENGELS M A,BOERMA G J,et al.Changes in bone mineral density, body composition,and lipid metablism during growth hormone (GH) treatment in children with GH deficiency [J].J Clin Endocrinol Metab,1997,82(8 ):2 423-2 428.
